Use of neuroimaging in acute stroke trials

Expert Review of Neurotherapeutics

Volumn 9, Issue 6, 2009, Pages 885-895

  Alexandrov, Andrei V ^a   Rubiera, Marta ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute stroke; Clinical trials; CT; MRI; Neuroimaging; Penumbra; Perfusion

Indexed keywords

BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FOLLOW UP; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; REVIEW; STROKE;

ACUTE DISEASE; CLINICAL TRIALS AS TOPIC; DIAGNOSTIC IMAGING; NEURORADIOGRAPHY; STROKE;

EID: 67650187971     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.09.33     Document Type: Review

References (56)

1. Di Carlo A, Launer LJ, Breteler MM et al. Frequency of stroke in Europe: a collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology 54(11 Suppl. 5), S28-S33 (2000).
2. Bejot Y, Benatru I, Rouaud O et al. Epidemiology of stroke in Europe: geographic and environmental differences. J. Neurol. Sci. 262(1-2), 85-88 (2007). (Pubitemid 47390898)
3. Higashida RT, Furlan AJ, Roberts H et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34(8), e109-e137 (2003).
4. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274(13), 1017-1025 (1995).
5. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke 31(4), 811-816 (2000).
6. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359(13), 1317-1329 (2008).
7. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34(2), 575-583 (2003). (Pubitemid 36206368)
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333(24), 1581-1587 (1995).
9. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 352(9136), 1245-1251 (1998).
10. Grotta JC, Chiu D, Lu M et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 30(8), 1528-1533 (1999). (Pubitemid 29379597)
11. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355(9216), 1670-1674 (2000).
12. Pexman JH, Barber PA, Hill MD et al. Use of the Alberta stroke program early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am. J. Neuroradiol. 22(8), 1534-1542 (2001). • Description of a scale to unify conventional noncontrast computed tomography (CT) readings in acute ischemic strokes. (Pubitemid 32862265)
13. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 36(10), 2110-2115 (2005). (Pubitemid 41429229)
14. Dzialowski I, Hill MD, Coutts SB et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke 37(4), 973-978 (2006).
15. Hill MD, Rowley HA, Adler F et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34(8), 1925-1931 (2003). (Pubitemid 36944782)
16. Messe SR, Kasner SE, Chalela JA et al. CT-NIHSS mismatch does not correlate with MRI diffusion-perfusion mismatch. Stroke 38(7), 2079-2084 (2007) (Pubitemid 47012271)
17. Kohrmann M, Juttler E, Huttner HB, Nowe T, Schellinger PD. Acute stroke imaging for thrombolytic therapy - an update. Cerebrovasc. Dis. 24(2-3), 161-169 (2007). (Pubitemid 47295580)
18. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12(6), 723-725 (1985).
19. 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann. Neurol. 48(2), 228-235 (2000). (Pubitemid 30617042)
20. Maulaz A, Piechowski-Jozwiak B, Michel P, Bogousslavsky J. Selecting patients for early stroke treatment with penumbra images. Cerebrovasc. Dis. 20 (Suppl. 2), 19-24 (2005). (Pubitemid 44689456)
21. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 42(9), 1717-1723 (1992).
22. Kidwell CS, Saver JL, Mattiello J et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology 57(11), 2015-2021 (2001). (Pubitemid 33126868)
23. Kidwell CS, Saver JL, Mattiello J et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol. 47(4), 462-469 (2000). (Pubitemid 30194602)
24. Takasawa M, Jones PS, Guadagno JV et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 39, 870-877 (2008). • Interesting work comparing MRI and positron emission tomography perfusion imaging in acute strokes. (Pubitemid 351619576)
25. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn. Reson. Med. 36(5), 715-725 (1996). (Pubitemid 26376710)
26. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn. Reson. Med. 36(5), 726-736 (1996). (Pubitemid 26376711)
27. Siemonsen S, Fitting T, Thomalla G et al. T2′ imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology 248(3), 979-986 (2008). • Description of a new MRI sequence for imaging acute stroke that will probably be developed in the future.
28. Schramm P, Schellinger PD, Fiebach JB et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke 33(10), 2426-2432 (2002).
29. Koenig M, Klotz E, Luka B, Venderink DJ, Spittler JF, Heuser L. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology 209(1), 85-93 (1998). (Pubitemid 28464652)
30. Wintermark M, Reichhart M, Thiran JP et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann. Neurol. 51(4), 417-432 (2002). (Pubitemid 34260772)
31. Sasaki M, Kudo K, Oikawa H. CT perfusion for acute stroke: current concepts on technical aspects and clinical applications. Int. Congr. Ser. 1290, 30-36 (2006). (Pubitemid 43850891)
32. Wintermark M, Meuli R, Browaeys P et al. Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 68(9), 694-697 (2007). • Series comparing CT perfusion and MRI for tissue plasminogen activator (tPA) patient selection in 3-9-h time window. (Pubitemid 46667819)
33. Heiss WD. Imaging the penumbra: the pathophysiologic basis for therapy of ischemic stroke. Presented at: 10th International Symposium on Thrombolysis and Acute Stroke Therapy. Budapest, Hungary, 21-23 September 2008.
34. Handschu R, Garling A, Heuschmann PU, Kolominsky-Rabas PL, Erbguth F, Neundorfer B. Acute stroke management in the local general hospital. Stroke 32(4), 866-870 (2001). (Pubitemid 32285151)
35. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56(8), 1015-1020 (2001). (Pubitemid 32336306)
36. Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. Stroke 39(5), 1621-1628 (2008). •• Interesting information on the meeting 'Advance Neuroimaging for Acute Stroke Treatment', with a proposal for unified protocols of neuroimaging for future stroke studies.
37. Wintermark M, Albers GW, Alexandrov AV et al. Acute stroke imaging research roadmap. AJNR Am. J. Neuroradiol. 29(5), e23-e30 (2008). (Pubitemid 351684949)
38. Warach S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr. Control Trials Cardiovasc. Med. 2, 38-44 (2001). (Pubitemid 32219923)
39. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med. 34(4), 555-566 (1995).
40. Fiehler J, Albers GW, Boulanger JM et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke 38(10), 2738-2744 (2007). (Pubitemid 47494012)
41. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruprion in human focal brain ischemia. Ann. Neurol. 56(4), 468-477 (2004). (Pubitemid 39319336)
42. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 36(10), 2311-2320 (2005). (Pubitemid 41429268)
43. Ritzl A, Meisel S, Wittsack HJ et al. Development of brain infarct volume as assessed by magnetic resonance imaging (MRI): follow-up of diffusion-weighted MRI lesions. J. Magn. Reson. Imaging 20(2), 201-207 (2004). (Pubitemid 38970927)
44. Albers GW, Thijs VN, Wechsler L et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol. 60(5), 508-517 (2006). • Observational study that evaluated response to tPA from 3 to 6 h according to the presence of diffusion-weighted imaging/perfusion-weighted imaging mismatch. (Pubitemid 44871793)
45. Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 7(4), 299-309 (2008). * Randomized trial of tPA versus placebo from 3 to 6 h with neuroimaging surrogate markers of efficacy.
46. Ribo M, Molina CA, Rovira A et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 36(3), 602-606 (2005). (Pubitemid 40344163)
47. Schellinger PD, Fiebach JB, Jansen O et al. Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia. Ann. Neurol. 49(4), 460-469 (2001). (Pubitemid 32281329)
48. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a Phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36(1), 66-73 (2005). (Pubitemid 40054177)
49. Furlan AJ, Eyding D, Albers GW et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37(5), 1227-1231 (2006). (Pubitemid 43731867)
50. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J. Neurol. Neurosurg. Psychiatry 78(5), 485-491 (2007). •• Interesting revision of the real evidence of penumbra imaging at present. (Pubitemid 46662896)
51. Kidwell CS, Alger JR, Saver JL. Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke 35, 2662-2665 (2004). 101 Third International Stroke Trial (IST III) www.dcn.ed.ac.uk/ist3 (Pubitemid 39461995)
52. Desmoteplase in Acute Stroke II (DIAS II). Identifier: NCT00111852. www.clinicaltrials.gov
53. MR and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) [SPOTRIAS]. Identifier: NCT00389467. www.clinicaltrials.gov
54. Alzheimer's Disease Neuroimaging Initiative www.loni.ucla.edu/ADNI/
55. Cancer Biomedical Informatics Grid™ (caBIG®) https://cabig.nci.nih.gov
56. International Consortium for Brain Mapping www.loni.uda.edu/ICBM/About